Fagron NV 2023 AR2
The report highlights Fagron's strong performance in 2023, with revenue increasing by 11.6% to 763.0 million euros and REBITDA rising by 13.9% to 149.0 million euros. The company made significant progress on its ESG journey, with its science-based emission reduction targets validated by the Science Based Targets initiative (SBTi). Fagron expanded its footprint by entering the veterinary compounding market through the acquisition of Wildlife Pharmaceuticals in South Africa and announcing the acquisition of Parma Produkt in Hungary. Additionally, the company achieved a 24% reduction in carbon footprint intensity compared to 2019, meeting its 2023 target, and reported a sustainable employee engagement score of 84%.
Company: Fagron NV
Sector: Health Care
Country: Belgium
Year: 2023
Type: AR2
Pages: 218
Fagron NV
Annual Report
The report highlights Fagron's strong performance in 2023, with revenue increasing by 11.6% to 763.0 million euros and REBITDA rising by 13.9% to 149.0 million euros. The company made significant progress on its ESG journey, with its science-based emission reduction targets validated by the Science Based Targets initiative (SBTi). Fagron expanded its footprint by entering the veterinary compounding market through the acquisition of Wildlife Pharmaceuticals in South Africa and announcing the acquisition of Parma Produkt in Hungary. Additionally, the company achieved a 24% reduction in carbon footprint intensity compared to 2019, meeting its 2023 target, and reported a sustainable employee engagement score of 84%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees